Allergic Rhinitis
Conditions
Interventions
Treatment group:Snapping presses on bilateral Yingxiang points + rescue medication
Control group:Snapping presses on bilateral Yingxiang Para-points + rescue medication
Sponsors
Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ? Those who meet the diagnostic criteria for perennial allergic rhinitis. ? Those who are between the ages of 18-65, regardless of gender. ? Those who have been suffering from the disease for more than one year. ? Informed consent, volunteer to be tested, and sign an informed consent form.
Exclusion criteria
Exclusion criteria: ? Upper respiratory tract infection, eosinophilia, vasodilatory rhinitis, nasal polyps, bronchitis, pneumonia, asthma. ? Pregnant and lactating women. ? Serious diseases with severe primary heart, liver, lung, and kidney diseases affecting their survival. ? Those who cannot give full informed consent due to intellectual or behavioral disabilities. ? Suspected or confirmed history of alcohol or drug abuse. ? Patients who have used glucocorticosteroids for 1 month prior to the start of the study. ? Known allergies or contraindications to the experimental emergency drug or related drugs. ? Acceptance of other clinical trials within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Daily Composite Symptom and Medication Score (CSMS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analog (VAS) scoring of nasal symptoms;Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score; | — |
Countries
China
Contacts
Public ContactLi Lei
Xiyuan Hospital of China Academy of Chinese Medical Science
Outcome results
None listed